AXT (AXTI) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
8 Jul, 2026Executive summary
Q3 2025 revenue reached $28.0 million, up 56% sequentially and 18.2% year-over-year, driven by strong Indium Phosphide demand for data center and optical network applications, and supported by new export permits.
Indium Phosphide revenue hit $13.1 million, its highest since 2022, with export permits enabling significant shipments and a surge of over 250% sequentially.
Gross margin improved to 22.4% non-GAAP (22.3% GAAP), reflecting better product mix and higher volumes, though still below prior year levels.
Net loss attributable to the company was $1.9 million GAAP ($0.04/share), improved from $2.9 million in Q3 2024, with non-GAAP net loss at $1.2 million ($0.03/share).
Indium Phosphide order backlog exceeded $49 million, with customers placing longer-term orders due to export permit lead times.
Financial highlights
Q3 2025 revenue: $28.0 million, up from $18.0 million in Q2 2025 and $23.6 million in Q3 2024.
Non-GAAP gross margin was 22.4%, up from 8.2% in Q2 2025 and down from 24.3% in Q3 2024; GAAP gross margin was 22.3%.
Non-GAAP operating loss improved to $0.384 million from $6.1 million in Q2 2025 and $2.6 million in Q3 2024; GAAP operating loss was $1.1 million.
Cash and equivalents at September 30, 2025, were $31.2 million (some reports $23.1 million), down from $38.8 million a year earlier.
Inventory reduced by $2.4 million to $77.7 million, with reserves at $27.1 million.
Outlook and guidance
Q4 2025 revenue expected in the $27–$30 million range, contingent on export permit timing.
Non-GAAP net loss projected at $0.01–$0.03 per share; GAAP net loss at $0.03–$0.05 per share.
OpEx expected to rise to ~$9 million in Q4 due to year-end adjustments.
Management expects ongoing volatility due to trade tensions, tariffs, and export controls between the U.S. and China, impacting revenue and profitability.
Anticipates strong market trends in data center upgrades to drive meaningful growth and a return to profitability in 2026.
Latest events from AXT
- Annual Meeting adjourned to June 4, 2026, to encourage full shareholder voting participation.AXTI
Proxy filing18 May 2026 - Annual meeting adjourned for lack of quorum; reconvening June 4, 2026, with unchanged proposals.AXTI
Proxy filing15 May 2026 - Revenue up 39% to $26.9M, margins improved, and $632.5M raised for expansion amid trade risks.AXTI
Q1 202614 May 2026 - Key votes include director elections and a proposal to increase authorized common stock.AXTI
Proxy filing31 Mar 2026 - Annual meeting covers director elections, pay, auditor ratification, and share authorization increase.AXTI
Proxy filing31 Mar 2026 - Key votes include director elections, say-on-pay, auditor ratification, and share authorization increase.AXTI
Proxy filing20 Mar 2026 - AI-driven demand is fueling record backlog and capacity expansion, but export permits are the main bottleneck.AXTI
Q4 202519 Feb 2026 - Expanding indium phosphide capacity and targeting power amplifier growth with strong supply chain control.AXTI
27th Annual Needham Growth Conference3 Feb 2026 - Q2 revenue up 50% year-over-year, with strong AI and optical demand and improved margins.AXTI
Q2 20242 Feb 2026